Cargando…
Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. F...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956743/ https://www.ncbi.nlm.nih.gov/pubmed/29780916 http://dx.doi.org/10.1016/j.ajoc.2018.01.042 |
_version_ | 1783323939214196736 |
---|---|
author | van Zeeburg, Elsbeth J.T. Maaijwee, Kristel J.M. van Meurs, Jan C. |
author_facet | van Zeeburg, Elsbeth J.T. Maaijwee, Kristel J.M. van Meurs, Jan C. |
author_sort | van Zeeburg, Elsbeth J.T. |
collection | PubMed |
description | PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. Fundoscopy showed a fibrotic macular scar, a large subretinal hemorrhage, partly recent, combined with intraretinal fluid, blood, and hard exudates. RPE-choroid graft surgery was performed, and visual acuity improved to 20/32, and maintained up until 13.5 years postoperative. Microperimetry performed at the same time revealed a 3.4 dB sensitivity, with fixation on the graft. During the postoperative years glaucoma developed, an uveitis anterior was treated, and to treat a small Coats' like lesion; one bevacizumab injection was administered. CONCLUSIONS AND IMPORTANCE: A best corrected visual acuity of 20/32 could be achieved and maintained up to 13.5 years after an RPE-choroid graft transplantation, despite an unfavorable preoperative presentation and some early and late complications. This case is a proof of principle that an RPE-choroid graft harvested from the midperiphery can support the macular metabolism up to 13.5 after surgery in a patient with severe exudative AMD. It also represents a rationale for pursuing stem cell derived RPE replacement. Anti-vascular endothelial growth factor injections are nowadays the mainstay of therapy for choroidal neovascularization and/or small hemorrhages and offer good results. Nevertheless, selected patients that cannot benefit from this therapy may profit from an autologous RPE-choroid graft transplantation. |
format | Online Article Text |
id | pubmed-5956743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-59567432018-05-18 Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation van Zeeburg, Elsbeth J.T. Maaijwee, Kristel J.M. van Meurs, Jan C. Am J Ophthalmol Case Rep Brief report PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. Fundoscopy showed a fibrotic macular scar, a large subretinal hemorrhage, partly recent, combined with intraretinal fluid, blood, and hard exudates. RPE-choroid graft surgery was performed, and visual acuity improved to 20/32, and maintained up until 13.5 years postoperative. Microperimetry performed at the same time revealed a 3.4 dB sensitivity, with fixation on the graft. During the postoperative years glaucoma developed, an uveitis anterior was treated, and to treat a small Coats' like lesion; one bevacizumab injection was administered. CONCLUSIONS AND IMPORTANCE: A best corrected visual acuity of 20/32 could be achieved and maintained up to 13.5 years after an RPE-choroid graft transplantation, despite an unfavorable preoperative presentation and some early and late complications. This case is a proof of principle that an RPE-choroid graft harvested from the midperiphery can support the macular metabolism up to 13.5 after surgery in a patient with severe exudative AMD. It also represents a rationale for pursuing stem cell derived RPE replacement. Anti-vascular endothelial growth factor injections are nowadays the mainstay of therapy for choroidal neovascularization and/or small hemorrhages and offer good results. Nevertheless, selected patients that cannot benefit from this therapy may profit from an autologous RPE-choroid graft transplantation. Elsevier 2018-02-01 /pmc/articles/PMC5956743/ /pubmed/29780916 http://dx.doi.org/10.1016/j.ajoc.2018.01.042 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Brief report van Zeeburg, Elsbeth J.T. Maaijwee, Kristel J.M. van Meurs, Jan C. Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title | Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title_full | Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title_fullStr | Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title_full_unstemmed | Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title_short | Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
title_sort | visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation |
topic | Brief report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956743/ https://www.ncbi.nlm.nih.gov/pubmed/29780916 http://dx.doi.org/10.1016/j.ajoc.2018.01.042 |
work_keys_str_mv | AT vanzeeburgelsbethjt visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation AT maaijweekristeljm visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation AT vanmeursjanc visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation |